Pathway Genomics Stock
Genetic DNA Testing Company
Sign up today and learn more about Pathway Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Pathway Genomics Stock
Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.
Investors
IBM Ventures
Welltok, Apttus, Digital Asset, Lightbend, IFTTT, Pathway Genomics
Funding History
| July 2009 | $3.0M |
|---|---|
| January 2016 | $40.0M |
Management
Chief Laboratory Officer & Medical Director
Nilesh Dharajiya, M.D.
Chief Business Officer
K'Lene Oen
Chief Financial Officer
Kamal Adawi
Executive Vice President, Domestic Sales
Anthony Facinelli
Chief Scientific Officer
Anja Kammesheidt, Ph.D.
Vice President of Business Development and Government Relations
Mitch Mulanix
Chief Medical Officer
Glenn D. Braunstein, M.D.
Founder and CEO
James Plante
Chief Privacy and Compliance Officer
Michael H. Cox, CIPP
Chief Innovation Officer
Michael Nova, M.D.
Press
prweb - Jun, 17 2020
Gateway Genomics Announces Partnership with Any Lab Test Now, Increasing Accessibility of the SneakPeek Early Gender DNA Testgenomeweb - Feb, 15 2020
Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellnessgenomeweb - Feb, 15 2020
Amid Customer Complaints, Genetic Testing Firm Pathway OME Acquired by OME Wellnessmarketwatch - Sep, 30 2019
Genetic Testing Market Forecast 2024 By GeneDx , Invitae , Pathway Genomics , Counsyl Inc , Asper Biotech , GenePlanetprnewswire - Aug, 23 2019
Raken Adds to Executive Team to Bolster Growth Strategysandiegouniontribune - May, 15 2018
Tell us about your experience with 23andMe, Pathway Genomics and other gene testing companiesprnewswire - Mar, 27 2018
Wellness Is More Than Skin Deepprnewswire - Jan, 19 2018
The Market for Direct-to-Consumer Genetic Health Testing, with Key Focus on Quest Diagnostics and LabCorporlandosentinel - Dec, 7 2017
An Epic quest to detect cancerprnewswire - Sep, 5 2017
Worldwide Liquid Biopsy Market, 2021 by Screening/Drug Monitoring/Diagnosticcnbc - May, 26 2017
12. 23andMeprnewswire - May, 1 2017
Research and Markets - Global Predictive Genetic Testing And Consumer/Wellness Genomics Market 2013-2017 & 2025: Key Players are BGI, Illumina, Pathway Genomics, Genesis, 23andMe, ARUP, Color Genomics & Myriadnanalyze - Apr, 18 2017
8 Blood Tests for Cancer Being Developed by Startupsmedcitynews - Mar, 31 2017
Mayo Clinic startup OneOme pitches user-friendly pharmacogenomicstechweekeurope - Jan, 11 2017
IBM Opens Watson Health HQ, Expands Watson Health CloudYahoo Finance - Jan, 2 2017
Pathway Genomics to participate in NASDAQ Fit Weekbusinesswire - Dec, 14 2016
Elevated Cancer Risk Revealed by Personal Genomic Testing Doesn’t Change Behavior, City of Hope Study Suggestsmedcitynews - Dec, 13 2016
The past, present and future of FDA regulation of LDTsbusinesswire - Dec, 10 2016
Pathway Genomics to Present & Exhibit at the 24medcitynews - Dec, 9 2016
App combining genomics, fitness and diet highlights nutrigenomics trendbusinesswire - Oct, 30 2016
Pathway Genomics’ Chief Financial Officer, Kamal Adawi, to Present at the 28th Annual Piper Jaffray Healthcare Conferencebusinessinsider - Jul, 14 2016
Investors are backing more AI startups than ever beforebusinessinsider - Jun, 25 2016
Investors are backing more AI startups than ever beforebusinesswire - May, 26 2016
Pathway Genomics Provides Updates for CancerInterceptextremetech - May, 22 2016
What is ‘smart’ nutrition, and how will it revolutionize food?businessinsider - May, 21 2016
A cutting-edge cancer testing company is suing one of its biggest rivalsprweb - Apr, 30 2016
BaseHealth Names Ardy Arianpour as Chief Business Officerbusinessinsider - Mar, 3 2016
Patients get mixed reactions from docs over mail-ordered genetic testsmedcitynews - Mar, 2 2016
23andMe could sell its spit kits at Walgreensmedcitynews - Jan, 22 2016
20 key players in the direct-to-consumer lab testing marketabqjournal - Jan, 21 2016
Illumina makes big push in cancer screeningbusinessinsider - Jan, 17 2016
Bill Gates is betting on a new company that just raised $100 million to create 'a simple blood test for every form of cancer'networksasia - Jan, 16 2016
Pathway Genomics introduces first wellness app powered by IBM Watsonprweb - Jan, 16 2016
MolecularMatch Adds Key Staff to Support Upcoming Product Launchstrictlyvc - Jan, 15 2016
StrictlyVC: January 5, 2016inc - Jan, 15 2016
Dear Obama, Here Are the 'Moonshot' Companies You Asked for Last Nightbusinessinsider - Jan, 13 2016
A startup just raised $100 million to create a simple blood test for every form of cancer and Bill Gates investedutsandiego - Jan, 13 2016
S.D. genomics firm settles whistleblower suitgeekwire - Jan, 12 2016
Bill Gates and Jeff Bezos invest in Grail, Illumina’s $100M cancer testing ventureBio-IT World - Jan, 12 2016
Pathway Genomics, IBM Health Appfastcompany - Jan, 12 2016
Bill Gates, Illumina To Fund $100M Blood Test For Cancermedcitynews - Jan, 12 2016
The competition: Who is Illumina’s new $100M startup, Grail, up against in cancer liquid biopsy screening?technologyreview - Jan, 12 2016
Illumina’s Bid to Beat Cancer with DNA Testsprnewswire - Jan, 12 2016
Sanford Heisler Kimpel, LLP Announces Qui Tam Settlement By Pathway Genomics Corp.medcitynews - Jan, 12 2016
Pathway Genomics pays more than $4M to settle kickback allegations from DOJbusinessinsider - Jan, 11 2016
Illumina is teaming up with Bill Gates and Jeff Bezos to develop a new kind of cancer testtech - Jan, 10 2016
CES 2016: When IBM’s Watson charts out gene-based diet plans and powers empathetic robotseweek - Jan, 10 2016
IBM, Pathway Genomics Launch Watson-Based Wellness Appprnewswire - Jan, 8 2016
Pathway Genomics Debuts First Genomic Wellness App Powered by IBM Watsonzdnet - Jan, 8 2016
IBM's Watson-powered wellness app with Pathway Genomics enters alpha releasemedcitynews - Jan, 8 2016
Pathway Genomics latest app combines cognitive computing, genetics and personal wellnessPR Newswire (press release) - Jan, 5 2016
Pathway Genomics Corporation Raises $40 Million In Series E Financingprnewswire - Dec, 31 2015
Pathway Genomics Announces Definitive Settlement With United Statesmedcitynews - Nov, 12 2015
Circulogene launches new liquid biopsy test for cancerbusinessinsider - Nov, 5 2015
Case for testing cancer in blood builds, one study at a timewired - Sep, 29 2015
Last chance: let the FDA know why you want direct access to your own genomewired - Sep, 29 2015
Should you trust a direct-to-consumer genetic test?wired - Sep, 29 2015
Is the FDA planning to strangle the supply lines of direct-to-consumer genomics companies?wired - Sep, 29 2015
Personal genomics is getting serious: Counsyl emerging from stealth modexconomy - Sep, 29 2015
West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and Moresocaltech - Sep, 29 2015
Pathway Genomics Lands Investment From Googlewired - Sep, 29 2015
A sad day for personal genomicswired - Sep, 29 2015
Personal genomics linksbloomberg - Sep, 29 2015
Do Genetic Tests Need Doctors? FDA Defends Its Challenge to 23andMewired - Sep, 29 2015
Why I now pay for online news, in two words: Mark Hendersonwired - Sep, 29 2015
FDA Meets With Industry, Experts To Discuss Future of Consumer Geneticsbusinesswire - Sep, 29 2015
Former Administrator of the U.S. Small Business Administration Hector Barreto Joins Pathway Genomics’ Strategic Advisory Boardsocaltech - Sep, 29 2015
Pathway Genomics Names SBA's Barreto As Advisorprnewswire - Sep, 29 2015
Molecular Diagnostics Market 2015 Update: Deal Trends, Cancer Testing, Strategic Assessments of Major Suppliers and More in New Research Reportstech - Sep, 29 2015
Your Genetics are a Road Map to Health and Wellnessbusinesswire - Sep, 29 2015
Pathway Genomics Adds Digital Health Entrepreneur Paul Sonnier to Strategic Advisory Boardsocaltech - Sep, 29 2015
Pathway Genomics Adds Advisorbusinesswire - Sep, 29 2015
Pathway Genomics Launches First Hispanic Targeted Screening Panel for BRCA1/2-Related Hereditary Cancersbusinesswire - Sep, 29 2015
Pathway Genomics Launches First Hispanic Targeted Screening Panel for BRCA1/2-Related Hereditary Cancersbusinesswire - Sep, 29 2015
Former Chairman of the Joint Chiefs of Staff U.S. General Peter Pace Joins Pathway Genomics Board of Directorsbusinesswire - Sep, 29 2015
Former Chairman of the Joint Chiefs of Staff U.S. General Peter Pace Joins Pathway Genomics Board of Directorswired - Sep, 29 2015
Where to next for personal genomics?businesswire - Sep, 29 2015
Jim Plante, Founder and CEO of Pathway Genomics, Appointed by US Secretary of Commerce and US Trade Secretary to Industry Trade Advisory Committee (ITAC)wired - Sep, 29 2015
Congress Opens Investigation Into Genetic Testing Companiesfiercebiotech - Sep, 29 2015
Ex-Pfizer SVP takes the helm at BioClinicaarstechnica - Sep, 29 2015
FDA wants safety, accuracy data on consumer genetic testsxconomy - Sep, 26 2015
West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More | Xconomytheverge - Sep, 10 2015
Live Photos could be Apple’s most disruptive new techtheverge - Sep, 10 2015
Startup claims its test finds cancer early, but where’s the evidence?Business Wire (press release) - Aug, 6 2015
Pathway Genomics Launches $99 Pathway Fit Genetic Test For a Limited Timezdnet - May, 22 2015
IBM's Watson Group invests in Pathway Genomics, eyes consumer wellness app | ZDNetxconomy - May, 22 2015
San Diego Life Sciences Roundup: Halozyme, Pathway Genomics, Avanir | Xconomywired - May, 21 2015
A sad day for personal genomics | WIREDwired - May, 21 2015
Personal genomics is getting serious: Counsyl emerging from stealth mode | WIREDtheverge - May, 21 2015
A Times reporter took three genetic tests and got three wildly different answerswired - May, 21 2015
FDA Meets With Industry, Experts To Discuss Future of Consumer Genetics | WIREDwired - May, 21 2015
Should you trust a direct-to-consumer genetic test? | WIREDwired - May, 21 2015
Is the FDA planning to strangle the supply lines of direct-to-consumer genomics companies? | WIREDwired - May, 21 2015
Where to next for personal genomics? | WIREDventurebeat - May, 20 2015
How IBM's Watson could be good for your health | VentureBeat | Big Data | by Jordan Novetventurebeat - May, 20 2015
Founders Fund will give dough to early-stage science startups | VentureBeat | Deals | by Jordan Noveteweek - May, 20 2015
IBM Invests in WayBlazer, Sellpoints to Advance Watson Ecosystemventurebeat - May, 19 2015
Personalization as a Service: new revenue stream for IBM Watson?gigaom - May, 12 2015
The Data Doc: Meet the MD who wants to bring custom healthcare to the massesgigaom - May, 12 2015
IBM Watson invests in personal health companygizmodo - May, 12 2015
IBM's Watson Will Give You Personalized Health Advice Based on Your DNAarstechnica - May, 12 2015
FDA wants safety, accuracy data on consumer genetic testsarstechnica - Apr, 29 2015
Patent litigation over human gene breast cancer testing is endingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
